Concepts (95)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA, Viral | 6 | 2016 | 295 | 0.900 |
Why?
|
| Anal Canal | 3 | 2019 | 28 | 0.850 |
Why?
|
| AIDS Dementia Complex | 3 | 2017 | 107 | 0.800 |
Why?
|
| Anus Neoplasms | 3 | 2019 | 47 | 0.770 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2018 | 224 | 0.690 |
Why?
|
| HIV Infections | 7 | 2018 | 2207 | 0.670 |
Why?
|
| Human papillomavirus 16 | 1 | 2018 | 34 | 0.660 |
Why?
|
| Cognition Disorders | 3 | 2015 | 233 | 0.630 |
Why?
|
| Papillomavirus Infections | 2 | 2018 | 316 | 0.570 |
Why?
|
| Monocytes | 7 | 2019 | 258 | 0.540 |
Why?
|
| Viral Load | 4 | 2017 | 300 | 0.320 |
Why?
|
| Blood-Brain Barrier | 2 | 2019 | 153 | 0.310 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2021 | 178 | 0.290 |
Why?
|
| Early Detection of Cancer | 2 | 2019 | 292 | 0.270 |
Why?
|
| Precancerous Conditions | 2 | 2019 | 81 | 0.260 |
Why?
|
| Anti-HIV Agents | 3 | 2019 | 394 | 0.260 |
Why?
|
| Antiretroviral Therapy, Highly Active | 3 | 2018 | 219 | 0.260 |
Why?
|
| Mass Screening | 2 | 2019 | 427 | 0.260 |
Why?
|
| Adult | 11 | 2021 | 11034 | 0.210 |
Why?
|
| Lymphoma, B-Cell | 1 | 2021 | 22 | 0.200 |
Why?
|
| HIV Seropositivity | 2 | 2019 | 182 | 0.190 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2018 | 21 | 0.170 |
Why?
|
| Humans | 15 | 2021 | 34853 | 0.170 |
Why?
|
| Galectins | 1 | 2018 | 27 | 0.170 |
Why?
|
| Viremia | 1 | 2018 | 40 | 0.170 |
Why?
|
| Male | 11 | 2021 | 18870 | 0.160 |
Why?
|
| Antigens, CD | 1 | 2018 | 116 | 0.160 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2019 | 84 | 0.160 |
Why?
|
| Receptors, Cell Surface | 1 | 2018 | 135 | 0.160 |
Why?
|
| Family Characteristics | 1 | 2019 | 102 | 0.160 |
Why?
|
| Middle Aged | 6 | 2019 | 9642 | 0.160 |
Why?
|
| Female | 11 | 2021 | 19873 | 0.160 |
Why?
|
| Central Nervous System | 1 | 2018 | 130 | 0.160 |
Why?
|
| HIV-1 | 4 | 2019 | 678 | 0.150 |
Why?
|
| RNA, Viral | 1 | 2018 | 287 | 0.150 |
Why?
|
| Neuroprotective Agents | 1 | 2019 | 231 | 0.150 |
Why?
|
| Autopsy | 1 | 2016 | 40 | 0.150 |
Why?
|
| Cytokines | 2 | 2017 | 569 | 0.140 |
Why?
|
| Anti-Retroviral Agents | 1 | 2016 | 139 | 0.140 |
Why?
|
| Algorithms | 1 | 2018 | 435 | 0.130 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2015 | 9 | 0.130 |
Why?
|
| Burkitt Lymphoma | 1 | 2015 | 23 | 0.130 |
Why?
|
| Cognition | 2 | 2018 | 373 | 0.130 |
Why?
|
| Models, Biological | 1 | 2018 | 642 | 0.130 |
Why?
|
| Cell Movement | 1 | 2018 | 545 | 0.130 |
Why?
|
| Cyclohexanes | 1 | 2014 | 29 | 0.130 |
Why?
|
| Atrophy | 1 | 2014 | 40 | 0.130 |
Why?
|
| Sampling Studies | 1 | 2013 | 60 | 0.120 |
Why?
|
| Triazoles | 1 | 2014 | 85 | 0.120 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 600 | 0.120 |
Why?
|
| Lymphocytes | 1 | 2013 | 116 | 0.110 |
Why?
|
| Homosexuality, Male | 1 | 2018 | 438 | 0.110 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2014 | 214 | 0.110 |
Why?
|
| Papillomaviridae | 1 | 2012 | 125 | 0.100 |
Why?
|
| Brain | 2 | 2014 | 1268 | 0.090 |
Why?
|
| Cohort Studies | 1 | 2013 | 1422 | 0.090 |
Why?
|
| Puerto Rico | 1 | 2013 | 1352 | 0.080 |
Why?
|
| Hawaii | 1 | 2013 | 1878 | 0.080 |
Why?
|
| Neuropsychological Tests | 2 | 2018 | 255 | 0.070 |
Why?
|
| Thailand | 2 | 2015 | 48 | 0.070 |
Why?
|
| Prospective Studies | 3 | 2014 | 1353 | 0.070 |
Why?
|
| Child, Preschool | 2 | 2021 | 1318 | 0.060 |
Why?
|
| Adolescent | 3 | 2021 | 5035 | 0.050 |
Why?
|
| Anthracyclines | 1 | 2021 | 5 | 0.050 |
Why?
|
| Child | 2 | 2021 | 2875 | 0.050 |
Why?
|
| Survival Rate | 1 | 2021 | 310 | 0.050 |
Why?
|
| Neopterin | 1 | 2018 | 11 | 0.040 |
Why?
|
| Prognosis | 1 | 2021 | 707 | 0.040 |
Why?
|
| Biopsy | 1 | 2019 | 151 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 964 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2021 | 984 | 0.040 |
Why?
|
| Young Adult | 2 | 2021 | 4012 | 0.040 |
Why?
|
| Incidence | 1 | 2019 | 882 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2018 | 1056 | 0.030 |
Why?
|
| Receptors, CCR2 | 1 | 2015 | 26 | 0.030 |
Why?
|
| Age Factors | 1 | 2018 | 1007 | 0.030 |
Why?
|
| Neoplasm, Residual | 1 | 2015 | 13 | 0.030 |
Why?
|
| Risk Factors | 2 | 2013 | 3414 | 0.030 |
Why?
|
| Receptors, IgG | 1 | 2014 | 48 | 0.030 |
Why?
|
| Leukocyte Count | 1 | 2014 | 74 | 0.030 |
Why?
|
| Receptors, CCR5 | 1 | 2014 | 59 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2018 | 1442 | 0.030 |
Why?
|
| Disease Management | 1 | 2014 | 61 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2015 | 392 | 0.030 |
Why?
|
| Biomedical Research | 1 | 2018 | 371 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 841 | 0.030 |
Why?
|
| ROC Curve | 1 | 2013 | 138 | 0.030 |
Why?
|
| HIV | 1 | 2013 | 97 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2015 | 628 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2013 | 429 | 0.030 |
Why?
|
| Aged | 2 | 2014 | 6448 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2013 | 179 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 570 | 0.030 |
Why?
|
| Gene Expression | 1 | 2014 | 639 | 0.030 |
Why?
|
| Genotype | 1 | 2012 | 641 | 0.020 |
Why?
|
Agsalda-Garcia's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(95)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(11)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_